view all news & events
11/16/2026

Cannabis Telemedicine in Germany: Regulation, Market Entry, Advertising and Enforcement

How is the regulatory landscape for telemedicine evolving in Germany's medical cannabis market? What legal requirements apply to prescriptions, cross-border business models and advertising?

Our partners Margret Knitter, Head of Medical Cannabis, and Dr Oliver Stöckel, Head of Digital Health, address these questions in a guest article published by the international industry platform Business of Cannabis.

Entitled “Cannabis Telemedicine in Germany: Regulation, Market Entry, Advertising and Enforcement”, the article examines the complex legal framework governing telemedicine platforms and providers in the medical cannabis sector. Key topics include the regulatory requirements for telemedical treatment, cross-border services within the EU, advertising restrictions and recent legal developments in Germany.

The article provides practical insights into the opportunities and legal challenges facing companies operating in or seeking to enter the German medical cannabis market.

Read the full article on Business of Cannabis here.

    Share

  • LinkedIn
  • XING